FARSA, Oldřich, Veronika BALLAYOVÁ, Radka ŽÁČKOVÁ, Peter KOLLÁR, Tereza KAUEROVÁ a Peter ZUBÁČ. Aminopeptidase N Inhibitors as Pointers for Overcoming Antitumor Treatment Resistance. International Journal of Molecular Sciences. Basel: Multidisciplinary Digital Publishing Institute, 2022, roč. 23, č. 17, s. 1-15. ISSN 1422-0067. Dostupné z: https://dx.doi.org/10.3390/ijms23179813.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Aminopeptidase N Inhibitors as Pointers for Overcoming Antitumor Treatment Resistance
Autoři FARSA, Oldřich (203 Česká republika, domácí), Veronika BALLAYOVÁ (703 Slovensko, garant, domácí), Radka ŽÁČKOVÁ (203 Česká republika, domácí), Peter KOLLÁR (203 Česká republika, domácí), Tereza KAUEROVÁ (203 Česká republika, domácí) a Peter ZUBÁČ (703 Slovensko, domácí).
Vydání International Journal of Molecular Sciences, Basel, Multidisciplinary Digital Publishing Institute, 2022, 1422-0067.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30104 Pharmacology and pharmacy
Stát vydavatele Švýcarsko
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 5.600
Kód RIV RIV/00216224:14160/22:00126601
Organizační jednotka Farmaceutická fakulta
Doi http://dx.doi.org/10.3390/ijms23179813
UT WoS 000851097400001
Klíčová slova anglicky aminopeptidase N; acetamidophenones; Schiff bases; semicarbazones; thiosemicarbazones; inhibition of proliferation
Štítky rivok, ÚChL, ÚFTo
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: JUDr. Sabina Krejčiříková, učo 383857. Změněno: 1. 2. 2023 13:58.
Anotace
Aminopeptidase N (APN), also known as CD13 antigen or membrane alanyl aminopeptidase, belongs to the M1 family of the MA clan of zinc metallopeptidases. In cancer cells, the inhibition of aminopeptidases including APN causes the phenomenon termed the amino acid deprivation response (AADR), a stress response characterized by the upregulation of amino acid transporters and synthetic enzymes and activation of stress-related pathways such as nuclear factor kB (NFkB) and other pro-apoptotic regulators, which leads to cancer cell death by apoptosis. Recently, APN inhibition has been shown to augment DR4-induced tumor cell death and thus overcome resistance to cancer treatment with DR4-ligand TRAIL, which is available as a recombinant soluble form dulanermin. This implies that APN inhibitors could serve as potential weapons for overcoming cancer treatment resistance. In this study, a series of basically substituted acetamidophenones and the semicarbazones and thiosemicarbazones derived from them were prepared, for which APN inhibitory activity was determined. In addition, a selective anti-proliferative activity against cancer cells expressing APN was demonstrated. Our semicarbazones and thiosemicarbazones are the first compounds of these structural types of Schiff bases that were reported to inhibit not only a zinc-dependent aminopeptidase of the M1 family but also a metalloenzyme.
Návaznosti
MUNI/A/1682/2020, interní kód MUNázev: Návrh, syntéza a hodnocení derivátů skupin léčiv s inhibiční enzymatickou aktivitou
Investor: Masarykova univerzita, Návrh, syntéza a hodnocení derivátů skupin léčiv s inhibiční enzymatickou aktivitou
MUNI/IGA/0932/2021, interní kód MUNázev: Basic ketones and their derivatives as potential anti-infective and anti-tumor drugs
Investor: Masarykova univerzita, Basic ketones and their derivatives as potential anti-infective and anti-tumor drugs
VytisknoutZobrazeno: 13. 7. 2024 22:34